Literature DB >> 29507018

Acute demyelinating neuropathy in a patient with neurolymphomatosis.

Rola A Mahmoud1, Charles K Abrams2.   

Abstract

Peripheral neurological complications of lymphomas are rare and much less frequent than central complications. Nonetheless, on occasion, systemic non-Hodgkin's lymphoma may directly infiltrate the peripheral nervous system at various levels. This report describes a man with non-Hodgkin's lymphoma and leptomeningeal disease who developed progressive areflexic quadraparesis. Initial electromyography (EMG) was consistent with a polyradiculopathy and a repeat EMG performed 1 month later for worsening symptoms showed evidence of demyelination. The patient expired due to systemic complications of his illness. Autopsy of the sural nerve showed moderately severe distal sensory axonal loss, direct infiltration of the brachial plexus by malignant lymphocytes and demyelination in brachial and lumbar plexus, most prominent in areas of neoplastic infiltration. Based on this patient's course and pathology, we suggest that widespread demyelination may accompany neurolymphomatosis and the clinical presentation may be indistinguishable from an acute demyelinating neuropathy. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  malignant and benign haematology; neuromuscular disease; neurooncology

Mesh:

Year:  2018        PMID: 29507018      PMCID: PMC5847896          DOI: 10.1136/bcr-2017-222814

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Neurolymphomatosis.

Authors:  Joachim Baehring; Dennis Cooper
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

Review 2.  Marek's disease lymphoma of chicken and its causative herpesvirus.

Authors:  K Nazerian
Journal:  Biochim Biophys Acta       Date:  1979-11-30

3.  Relapse of central nervous system Burkitt's lymphoma presenting as Guillain-Barre syndrome and syndrome of inappropriate ADH secretion.

Authors:  T G Phan; A Manoharan; D Pryor
Journal:  Aust N Z J Med       Date:  1998-04

Review 4.  Diagnosis and management of neurolymphomatosis.

Authors:  Joachim M Baehring; Tracy T Batchelor
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

5.  Neurolymphomatosis.

Authors:  Joachim M Baehring; Denise Damek; Emily C Martin; Rebecca A Betensky; Fred H Hochberg
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

6.  Fatal peripheral neurolymphomatosis after remission of histiocytic lymphoma.

Authors:  Y Shoenfeld; D Aderka; U Sandbank; N Gadot; M Santo; J Pinkhas
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

Review 7.  Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations.

Authors:  Haruki Koike; Fumiaki Tanaka; Gen Sobue
Journal:  Curr Opin Neurol       Date:  2011-10       Impact factor: 5.710

8.  Neurolymphomatosis: a clinicopathologic syndrome re-emerges.

Authors:  R Diaz-Arrastia; D S Younger; L Hair; G Inghirami; A P Hays; D M Knowles; J G Odel; M R Fetell; R E Lovelace; L P Rowland
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

Review 9.  Lymphoma and peripheral neuropathy: a clinical review.

Authors:  John J Kelly; Donald S Karcher
Journal:  Muscle Nerve       Date:  2005-03       Impact factor: 3.217

Review 10.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.